Compound
ganglioside GD1a (18:1(4E)/18:0)
A α-N-acetylneuraminosyl-(2→3)-β-D-galactosyl-(1→3)-N-acetyl-β-D-galactosaminyl-(1→4)-[α-N-acetylneuraminosyl-(2→3)]-β-D-galactosyl-(1→4)-β-D-glucosylceramide(2−) in which the ceramide N-acyl group is specified as octadecanoyl (stearoyl).
Definition from ChEBI (CHEBI:90153), read 2026-09-23. CC BY 4.0.
Structure
- Class
- Organic compound, anion
- Formula
- C84H146N4O39
- Mass
- 1836.081 g/mol
- Charge
- -2
- InChIKey
- RXIWRIRPTSKUTD-BFJDPXHSSA-L
- SMILES
- [H][C@@]1([C@H](O)[C@H](O)CO)O[C@@](O[C@H]2[C@@H](O)[C@@H](CO)O[C@@H](O[C@H]3[C@@H](O)[C@@H](CO)O[C@@H](O[C@@H]4[C@H](O[C@]5(C(=O)[O-])C[C@H](O)[C@@H](NC(C)=O)[C@]([H])([C@H](O)[C@H](O)CO)O5)[C@@H](O)[C@H](O[C@H]5[C@H](O)[C@@H](O)[C@H](OC[C@H](NC(=O)CCCCCCCCCCCCCCCCC)[C@H](O)/C=C/CCCCCCCCCCCCC)O[C@@H]5CO)O[C@@H]4CO)[C@@H]3NC(C)=O)[C@@H]2O)(C(=O)[O-])C[C@H](O)[C@H]1NC(C)=O
- Look it up
- ChEBIBy InChIKey
Identity from ChEBI. Not evidence.
What it touches on the way
Mechanistic reach
2 entities
2 entities reached.
0 reported hops2 assembled from the scaffold
What the reference databases state
Statements
2 statements
2 statements · 1 reference database · Subject: ganglioside GD1a (18:1(4E)/18:0) · Sources: Rhea
- ganglioside GD1a (18:1(4E)/18:0) is a substrate of ST3GAL1ProteinRhea RHEA:48248Inferred only
- ganglioside GD1a (18:1(4E)/18:0) is a substrate of ST3GAL2ProteinRhea RHEA:48248Inferred only
Reactions
1 reaction
ganglioside GM1 (d18:1(4E)/18:0)+CMP-N-acetyl-beta-neuraminateganglioside GD1a (18:1(4E)/18:0)+CMP+hydron
Catalysed by ST3GAL1 or ST3GAL2
Reaction pageLeft to rightBalance undeterminable
Rhea RHEA:48248CC BY 4.0Reference data
Other names
10 names
Resolves to: ganglioside GD1a (18:1(4E)/18:0)
- Also called
- (2S,3R,4E)-3-hydroxy-2-(octadecanoylamino)octadec-4-en-1-yl 5-acetamido-3,5-dideoxy-D-glycero-alpha-D-galacto-non-2-ulopyranonosyl-(2->3)-[5-acetamido-3,5-dideoxy-D-glycero-alpha-D-galacto-non-2-ulopyranonosyl-(2->3)-beta-D-galactopyranosyl-(1->3)-2-acetamido-2-deoxy-beta-D-galactopyranosyl-(1->4)]-beta-D-galactopyranosyl-(1->4)-beta-D-glucopyranoside(2S,3R,4E)-3-hydroxy-2-(octadecanoylamino)octadec-4-en-1-yl 5-acetamido-3,5-dideoxy-D-glycero-α-D-galacto-non-2-ulopyranonosyl-(2→3)-[5-acetamido-3,5-dideoxy-D-glycero-α-D-galacto-non-2-ulopyranonosyl-(2→3)-β-D-galactopyranosyl-(1→3)-2-acetamido-2-deoxy-β-D-galactopyranosyl-(1→4)]-β-D-galactopyranosyl-(1→4)-β-D-glucopyranosidealpha-N-acetylneuraminosyl-(2->3)-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-[alpha-N-acetylneuraminosyl-(2->3)]-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(11')-N-octadecanoylsphingosine(2-)alpha-Neup5Ac-(2->3)-beta-Galp-(1->3)-beta-GalpNAc-(1->4)-[alpha-Neup5Ac-(2->3)]-beta-Galp-(1->4)-beta-Glcp-(11')-Cer(d18:1/18:0)(2-)Ganglioside GD1a (d18:1(4E)/18:0)GD1a ganglioside (C18)(2-)GD1a ganglioside (C18)(2−)GD1a(d18:1(4E)/18:0)α-N-acetylneuraminosyl-(2→3)-β-D-galactosyl-(1→3)-N-acetyl-β-D-galactosaminyl-(1→4)-[α-N-acetylneuraminosyl-(2→3)]-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-N-octadecanoylsphingosine(2−)α-Neup5Ac-(2→3)-β-Galp-(1→3)-β-GalpNAc-(1→4)-[α-Neup5Ac-(2→3)]-β-Galp-(1→4)-β-Glcp-(1↔1')-Cer(d18:1/18:0)(2−)